Welcome : Guest

Bavarian Nordic A/S (Denmark) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Bavarian Nordic A/S, which is principally involved in Biotechnology Business. Illustrated with 46 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-07977
Price: $2300
Company Type: Public
Pages: 49
Date: October 2015
Market Data Tables: 46

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Bavarian Nordic AS’s Sales by Geographic Region Worldwide (2014) in Percentage for USA, Canada and Others......3
Table 2: Bavarian Nordic AS’s Sales by Category Worldwide (2014) in Percentage for Infectious Diseases (IMVAMUNE Sale and Contract Work)......4
Biopharmaceuticals......5
Table 3: Biopharmaceuticals Market by Region Worldwide (2015)-Percentage Share Breakdown by Value for Asia, Africa and Australia, Europe, US and Others......5
Pharmaceuticals......6
Table 4: Pharmaceuticals Market by Region in European Union (2014) - Percentage Share Breakdown by Value Sales for France, Germany, Great Britain, Italy, Spain, and Others......6
Table 5: Pharmaceuticals Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Asia, Africa, and Australasia, European Union, Japan, Latin America, and North America......7
Table 6: Pharmaceuticals Market by Therapeutic Area in China (2014) - Percentage Share Breakdown by Value Sales for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular Diseases, Musculo-Skeletal System, Nervous System, Oncology, Respiratory System, Systemic Anti- Infective, and Others......8
Table 7: Pharmacy Market by Category in Germany (2014) - Percentage Share Breakdown by Value Sales for Controlled Drugs, GSL Medicines, Drugs, Chemicals, Non-Drugs, Pharmacy only, and Prescription only......9
Cancer Market......10
Table 8: Cancer Care Expenditure by Site Worldwide (2014) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......10
Table 9: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......11
Table 10: Cancer-Associated Mucositis Market by Activity Worldwide (2015)-Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......12
Table 11: Cancer Market by Type in China (2015)-Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......13
Table 12: Number of Cancer Patients by Type in the US (2014) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......14
Table 13: Number of Cancer Patients by Type Worldwide (2014) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......15
Table 14: No. of Solid Cancer Tumor Patients by Type Worldwide (2014) – Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......16
Table 15: No. of Cancer Patients Death by Type in the US (2014) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......17
Table 16: No. of Bladder Cancer Patients by Category in the US (2014) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......18
Table 17: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......19
Table 18: No. of Primary Liver Cancer Patients by Region Worldwide (2015) – Percentage Market Share Breakdown for Asia, Australia, Europe, and US......20
Hematological Cancer......21
Table 19: Hematological Cancer by Category Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......21
Skin Cancer......22
Table 20: Skin Cancer by Type Worldwide (2014) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......22
Immunotherapy......23
Table 21: Allergy Immunotherapy Market by Region Worldwide (2015)-Percentage Share Breakdown by Value for Europe, France, Germany, Italy, Spain and Others......23
Table 22: Immunoassay Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Allergy, Autoimmunity, Bone and Mineral, Cardiac markers, GI Stool Testing, Hepatitis and Retroviruses, Infectious Diseases, Oncology & Endocrinology, and Others......24
Table 23: Immune Tolerance Therapy (Patient) Treatment for Hemophilia A Patients by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for 0-12, 13-21 and 22+......25
Intravenous Immunoglobulin (IVIG)......26
Table 24: Intravenous Immunoglobulin (IVIG) Therapy Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales, for Europe, US, and Others......26
Table 25: Intravenous Immunoglobulin (IVIG) Therapy Market by Region Worldwide (2014) - Percentage Share Breakdown by Volume Sales, for Europe, US, and Others......27
Table 26: Intravenous Immunoglobulin (IVIG) Usage by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Hematology and Oncology, Immune Thrombocytopenic Purpura (ITP), Neurology, Pelvic Inflammatory Disease (PID), and Others......28
Table 27: Intravenous Immunoglobulin (IVIG) Therapy by Disorders in the US (2014) - Percentage Market Share Breakdown by No. of Indications for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Chronic Lymphocytic Leukemia (CLL), Idiopathic Thrombocytopenic Purpura (ITP), Mismatch Negativity (MMN), Pelvic Inflammatory Disease (PID), and Others......29
Medical Therapy......30
Table 28: Medical Therapy Market by Category in the UK (2015) - Percentage Share Breakdown by Value for Immunotherapy and Symptomatic......30
Molecular Infectious Disease Diagnostics......31
Table 29: Molecular Infectious Disease Market by Panel Worldwide (2014) - Percentage Share Breakdown by Value Sales for BSI +/- (Sepsis), CSF, Enteric (GI), Fungal (Candida), HCV Genotyping, Respiratory, and STI......31
Table 30: Molecular Infectious Disease Diagnostic Equipment Market by Platform Worldwide (2014) - Percentage Share Breakdown by Value Sales for BioFire, LX 100/200 & MAGPIX, MALDI Biotyper, Verigene, XT-8, and Others......32
Table 31: Infectious Disease Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Molecular Diagnostics Infectious Diseases, and Others......33
Vaccines......34
Table 32: Vaccines Market by Segment Worldwide (2015)-Percentage Share Breakdown by Value for Adult Prophylactic Vaccines (USD 8.5bn), Pediatric Vaccines (USD 16.7bn) and Others......34
Biopharmaceuticals......35
Table 33: Market Shares of Leading Biopharmaceutical Companies in the US (2015) - Percentage Market Share Breakdown by Value for Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals, Inc., Celgene Corporation, Gilead Sciences, Inc., Incyte, Corporation, Isis Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., and Others......35
Pharmaceuticals Suppliers......36
Table 34: Leading Pharmaceuticals Suppliers to Germany by Region Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Belgium, France, Great Britain, Ireland, Italy, Netherlands, Spain, Sweden, Switzerland, USA, and Others......36
Immunoglobulin......37
Table 35: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Therapy Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Baxter International, Inc., Biotest AG, CSL Limited, Grifols, S.A., Talecris Biotherapeutics, Inc., Kedrion S.p.A., Octapharma AG, and Others......37
Table 36: Market Shares of Leading Immunology/ Immunoglobulin Providers in the US (2015) - Percentage Breakdown by Value for Baxter International Inc., CSL Limited, Grifols, S.A., and Others......38
Allergy Immunotherapy......39
Table 37: Market Shares of Leading Allergy Immunotherapy Treatment Providers in the UK (2015) - Percentage Breakdown by Value for ALK, Allergopharma, Allergy Therapeutics, HAL Allergy, Leti/Novartis, Stallergenes, and Others......39
Molecular Infectious Disease Equipment......40
Table 38: Market Shares of Leading Molecular Infectious Disease Diagnostic Equipment Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for BioMeriuex, Bruker Corporation, GenMark Diagnostics, Inc., Luminex Corporation, Nanosphere, Inc., and Others......40
Table 39: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......41
Vaccines......42
Table 40: Market Shares of Leading Vaccine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc (GSK), Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......42
Table 41: Market Shares of Leading Varilrix Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Varilrix), and Others......43
Table 42: Market Shares of Leading Vet Vaccine Manufacturing Companies in China (2015)-Percentage Share Breakdown by Value for China Animal Husbandry Industry Co., Ltd., Zhejiang Shenghua Biok Biology Co., Ltd., Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd. and Others......44
Table 43: Market Shares of Leading Diphtheria and Tetanus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Infanrix), and Others......45
Table 44: Market Shares of Leading Hepatitis A Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Havrix), and Others......46
Table 45: Market Shares of Leading Hepatitis B (Recombinant) Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Engerix (GlaxoSmithKline Plc), and Others......47
Table 46: Market Shares of Leading Human Rotavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Rotarix), and Others......48